Literature DB >> 22300502

Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice.

Lai Wang1, Wei Wang, Prediman K Shah, Lei Song, Mingjie Yang, Behrooz G Sharifi.   

Abstract

AIMS: Tenascin-C (TNC), a matricellular protein, is up-regulated in atherosclerotic plaques. We investigated whether the deletion of TNC gene affects the development of atherosclerosis in a murine model.
METHODS: TNC-/-/apo E-/- mice were generated and used for atherosclerosis studies. We compared these results to those observed in control groups of apo E-/- mice.
RESULTS: The en face analysis of aortic area showed that the mean aortic lesion area of the double knockout (KO) mice was significantly higher than that of control mice at different times after feeding of atherogenic diet; the accumulation of lesional macrophages and lipids was significantly higher. Analysis of cell adhesion molecules revealed that vascular cell adhesion molecule-1 (VCAM-1), but not intercellular adhesion molecule-1, was up-regulated 1 week after feeding of atherogenic diet in the double KO mouse as compared to apo E-/- mouse. Cell culture studies revealed that the expression of VCAM-1 in endothelial cells isolated from the double KO mouse is more sensitive to the tumor necrosis factor α stimulation than the cells isolated from apo E-/- mice. Cell adhesion studies showed that the adherence of RAW monocytic cells to the endothelial cells was significantly enhanced in the cultured endothelial cells from the TNC gene-deleted cells. Following the prolonged feeding of an atherogenic diet (28-30 weeks), the aortic and carotid atherosclerotic lesions frequently demonstrated large grossly visible areas of intraplaque hemorrhage in the double KO mice compared to control.
CONCLUSIONS: These data unveil a protective role for TNC in atherosclerosis and suggest that TNC signaling may have the potential to reduce atherosclerosis, in part by modulating VCAM-1 expression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22300502      PMCID: PMC3345312          DOI: 10.1016/j.carpath.2011.12.005

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  52 in total

1.  Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization.

Authors:  Victoria L T Ballard; Arti Sharma; Inga Duignan; Jacquelyne M Holm; Andrew Chin; Ruby Choi; Katherine A Hajjar; Shing-Chiu Wong; Jay M Edelberg
Journal:  FASEB J       Date:  2006-02-06       Impact factor: 5.191

2.  Destabilizing role of cathepsin S in murine atherosclerotic plaques.

Authors:  Kenneth J Rodgers; Deborah J Watkins; Alastair L Miller; Peter Y Chan; Sharada Karanam; William H Brissette; Clive J Long; Christopher L Jackson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-12       Impact factor: 8.311

3.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

4.  The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis.

Authors:  M J Davies; J L Gordon; A J Gearing; R Pigott; N Woolf; D Katz; A Kyriakopoulos
Journal:  J Pathol       Date:  1993-11       Impact factor: 7.996

5.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.

Authors:  Y Nakashima; E W Raines; A S Plump; J L Breslow; R Ross
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-05       Impact factor: 8.311

6.  Tenascin-C is an essential factor for neointimal hyperplasia after aortotomy in mice.

Authors:  Kiyohito Yamamoto; Koji Onoda; Yasuhiro Sawada; Kazuya Fujinaga; Kyoko Imanaka-Yoshida; Hideto Shimpo; Toshimichi Yoshida; Isao Yada
Journal:  Cardiovasc Res       Date:  2005-02-15       Impact factor: 10.787

7.  Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque.

Authors:  K Wallner; C Li; P K Shah; M C Fishbein; J S Forrester; S Kaul; B G Sharifi
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

8.  Bioengineered vascular graft grown in the mouse peritoneal cavity.

Authors:  Lei Song; Lai Wang; Prediman K Shah; Aurelio Chaux; Behrooz G Sharifi
Journal:  J Vasc Surg       Date:  2010-08-08       Impact factor: 4.268

9.  Deficiency of tenascin C attenuates allergen-induced bronchial asthma in the mouse.

Authors:  Hiroki Nakahara; Esteban C Gabazza; Hajime Fujimoto; Yoichi Nishii; Corina N D'Alessandro-Gabazza; Nelson E Bruno; Takehiro Takagi; Tatsuya Hayashi; Junko Maruyama; Kazuo Maruyama; Kyoko Imanaka-Yoshida; Koji Suzuki; Toshimichi Yoshida; Yukihiko Adachi; Osamu Taguchi
Journal:  Eur J Immunol       Date:  2006-12       Impact factor: 5.532

10.  Tenascin knockout mice: barrels, boundary molecules, and glial scars.

Authors:  D A Steindler; D Settles; H P Erickson; E D Laywell; A Yoshiki; A Faissner; M Kusakabe
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

View more
  11 in total

1.  Tenascin-C deficiency in apo E-/- mouse increases eotaxin levels: implications for atherosclerosis.

Authors:  Lai Wang; Prediman K Shah; Wei Wang; Lei Song; Mingjie Yang; Behrooz G Sharifi
Journal:  Atherosclerosis       Date:  2013-02-11       Impact factor: 5.162

2.  PDGF and TGF-β promote tenascin-C expression in subepithelial myofibroblasts and contribute to intestinal mucosal protection in mice.

Authors:  M S Islam; M Kusakabe; K Horiguchi; S Iino; T Nakamura; K Iwanaga; H Hashimoto; S Matsumoto; T Murata; M Hori; H Ozaki
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

3.  Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation.

Authors:  Lei Song; Lai Wang; Fuqiang Li; Ada Yukht; Minghui Qin; Haley Ruther; Mingjie Yang; Aurelio Chaux; Prediman K Shah; Behrooz G Sharifi
Journal:  J Am Coll Cardiol       Date:  2017-09-26       Impact factor: 24.094

4.  Tenascin-C is a driver of inflammation in the DSS model of colitis.

Authors:  James Ozanne; Brandon Shek; Louise A Stephen; Amanda Novak; Elspeth Milne; Gerry Mclachlan; Kim S Midwood; Colin Farquharson
Journal:  Matrix Biol Plus       Date:  2022-05-23

5.  Serum tenascin-C level is associated with coronary plaque rupture in patients with acute coronary syndrome.

Authors:  Nobuo Sakamoto; Yasuto Hoshino; Tomofumi Misaka; Hiroyuki Mizukami; Satoshi Suzuki; Koichi Sugimoto; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-ichi Saitoh; Yasuchika Takeishi
Journal:  Heart Vessels       Date:  2013-03-27       Impact factor: 2.037

6.  Splenocytes seed bone marrow of myeloablated mice: implication for atherosclerosis.

Authors:  Lai Wang; Mingjie Yang; Ana Arias; Lei Song; Fuqiang Li; Fang Tian; Minghui Qin; Ada Yukht; Ian K Williamson; Prediman K Shah; Behrooz G Sharifi
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

7.  Multiple Roles of Tenascins in Homeostasis and Pathophysiology of Aorta.

Authors:  Kyoko Imanaka-Yoshida; Ken-Ichi Matsumoto
Journal:  Ann Vasc Dis       Date:  2018-06-25

Review 8.  The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases.

Authors:  Ken-Ichi Matsumoto; Hiroki Aoki
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

Review 9.  Extracellular matrix synthesis in vascular disease: hypertension, and atherosclerosis.

Authors:  Markella Ponticos; Barbara D Smith
Journal:  J Biomed Res       Date:  2013-09-20

10.  Tenascin-c renders a proangiogenic phenotype in macrophage via annexin II.

Authors:  Zhiyang Wang; Qi Wei; Liang Han; Keqing Cao; Tianfeng Lan; Zhenjie Xu; Yingjuan Wang; Yuan Gao; Jing Xue; Fei Shan; Jun Feng; Xin Xie
Journal:  J Cell Mol Med       Date:  2017-08-30       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.